Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $44.6266 (-0.41%) ($44.3178 - $45.6868) on Fri. Mar. 21, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.99% (three month average) | RSI | 50 | Latest Price | $44.6266(-0.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 25.3% a day on average for past five trading days. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) VT(44%) EWG(6%) PCY(6%) PEJ(6%) EMHY(5%) | Factors Impacting ABBV price | ABBV will decline at least -0.495% in a week (0% probabilities). XLU(-3%) GLD(-3%) SLV(-2%) SHY(-2%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.495% (StdDev 0.99%) | Hourly BBV | 0 () | Intraday Trend | -1.4% | | | |
|
5 Day Moving Average | $44.3(0.74%) | 10 Day Moving Average | $0(0%) | 20 Day Moving Average | $0(0%) | To recent high | -0.4% | To recent low | 2.8% | Market Cap | $78.734b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |